Fiscal Year End Company Status Exempt Flag December 31 Trading N Board of Directors Name Position Douglas Janzen  President Noel Hall  Director of the Board Richard Barker  Director of the Board William Jarosz  Director of the Board Incorporation Locations Inc. Date Expiry Date Country Region Description 15/Feb/2005    Canada  British Columbia  Business Corporations Act  Exchange Filing Office Location Vancouver Regional Service Office		Business Type(s) Primary/Secondary Business Type Details Primary  Research and Development of Pharmaceutical Products  (not available)  Securities Symbol Security Name Market Status ICO iCo Therapeutics Inc TSX Venture TRADING Name History From To iCo Therapeutics Inc. 7/Jan/2008 Present Company Facts Reconciliation Subject Date Returned Spring 2012 CFR Not Received Associations Auditing Firm:  Price Waterhouse Coopers LLP Director of Corporate Development:  Frederica Bell Investor Relations:  Michael Moore Law Firm:  McCarthy Tetrault LLP Sponsor:  Canaccord Capital Corp. Transfer Agent:  Computershare Investor Services Inc.
Latest Information Type Date Title News Releases  24/May/2013  NEWS RELEASE - ICO THERAPEUTICS ANNOUNCES DIRECTOR ELECTION RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS[CANADA NEWSWIRE]     NEWS RELEASE - CLOSES $3.4 MILLION FINANCING[MARKET NEWS]     NEWS RELEASE - ICO THERAPEUTICS CLOSES $3.4 MILLION FINANCING[CANADA NEWSWIRE] Bulletins  10/May/2013  Resume Trading Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data